Radiopharmaceuticals Market Analysis 2019 - 2029

A recent market study published by Future Market Insights on the radiopharmaceuticals market includes global industry analysis for 2014 - 2018 & opportunity assessment for 2019 - 2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the radiopharmaceuticals market, the growth prospects of the market are obtained with maximum precision.

Radiopharmaceuticals Market: Segmentation

The global radiopharmaceuticals market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Radioisotope

Technetium-99
Fluorine-18
Iodine-131
Leutetium-177
Yttrium-90
Gallium-68
Gallium-67
Rubidium-82
Iodine-123
Iodine-125
Indium-111
Others
Application

Oncology
Cardiology
Gastroenterology
Neuroendocrinology
Neurology
Nephrology
Others
Source

Cyclotrons
Nuclear Reactors
End User

Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Cancer Research Institute
Region

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
MEA
Download Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1992



Report Chapters

Chapter 01 – Executive Summary

The report initiates with the executive summary of the radiopharmaceuticals market, which includes a summary of key findings and statistics of the market. It also includes drivers and trends pertaining to the radiopharmaceuticals market.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the radiopharmaceuticals market in this chapter, which will help them understand the basic information about the radiopharmaceuticals market. Along with this, comprehensive information pertaining to radiopharmaceuticals and their properties are provided in this section. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the radiopharmaceuticals market report.

Chapter 03 – Market Dynamics

This section gives information about drivers, and restraints of the radiopharmaceuticals market. This section also includes various opportunities and key trends of the radiopharmaceuticals market.

Chapter 04 – Market Context

This section gives information about upcoming pipeline products, PEST analysis, Porter’s Five Forces Model, and regulatory scenario of the radiopharmaceuticals market.

Chapter 05 – Global Radiopharmaceuticals Market Demand Analysis 2014 - 2018 & Opportunity Assessment 2019 - 2029

This section explains the global market value analysis and forecast for the radiopharmaceuticals market between the forecast periods of 2019 - 2029. This chapter includes a detailed analysis of the historical radiopharmaceuticals market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 06 – Global Radiopharmaceuticals Market Analysis 2014 - 2018 & Opportunity Assessment 2019 - 2029, by Radioisotope

Based on radioisotope, the radiopharmaceuticals market is segmented into Technetium-99, Fluorine-18, Iodine-131, Leutetium-177, Yttrium-90, Gallium-68, Gallium-67, Rubidium-82, Iodine-123, Iodine-125, Indium-111 and others. In this chapter, readers can find information about the key trends and developments in the radiopharmaceuticals market and market attractiveness analysis based on radioisotope.

Request For Table Of Content @ https://www.futuremarketinsights.com/reports/radiopharmaceuticals-market/table-of-content

Chapter 07 – Global Radiopharmaceuticals Market Analysis 2014 - 2018 & Opportunity Assessment 2019 - 2029, by Application

Based on application, the radiopharmaceuticals market is segmented into oncology, cardiology, gastroenterology, neuroendocrinology, neurology, nephrology and others. In this chapter, readers can understand the market attractive analysis based on application.

Chapter 08 – Global Radiopharmaceuticals Market Analysis 2014 - 2018 & Opportunity Assessment 2019 - 2029, by Source

Based on application, the radiopharmaceuticals market is segmented into cyclotrons and nuclear reactors. In this chapter, readers can understand the market attractive analysis based on source.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.



Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: [email protected]

For Media Enquiries: [email protected]